Skip to content
10-Q

Quarterly Report

ISTA PHARMACEUTICALS INC

0001193125-12-209560

← back to feed
Filed
May 4, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Mar 31, 2012 41.91M sh
Capex Q1 2012 · Mar 31, 2012 $496K
Capex Q1 2012 · Mar 31, 2011 $330K
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$9.01M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$3.14M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $53.69M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $71.59M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $75.76M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $78.78M
Stockholders Equity Q1 2012 · Mar 31, 2012 −$64.84M
Stockholders Equity Q1 2012 · Dec 31, 2011 −$49.07M
Current Liabilities Q1 2012 · Mar 31, 2012 $109.96M
Current Liabilities Q1 2012 · Dec 31, 2011 $137.85M
Total Liabilities Q1 2012 · Mar 31, 2012 $189.57M
Total Liabilities Q1 2012 · Dec 31, 2011 $202.16M
Current Assets Q1 2012 · Mar 31, 2012 $112.12M
Current Assets Q1 2012 · Dec 31, 2011 $140.12M
Total Assets Q1 2012 · Mar 31, 2012 $124.74M
Total Assets Q1 2012 · Dec 31, 2011 $153.09M
Sga Expense Q1 2012 · Mar 31, 2012 $28.4M
Sga Expense Q1 2012 · Mar 31, 2011 $26.93M
Rd Expense Q1 2012 · Mar 31, 2012 $9.49M
Rd Expense Q1 2012 · Mar 31, 2011 $10.34M
Net Income Q1 2012 · Mar 31, 2012 −$17.81M
Net Income Q1 2012 · Mar 31, 2011 −$84.07M
Operating Income Q1 2012 · Mar 31, 2012 −$1.61M
Operating Income Q1 2012 · Mar 31, 2011 −$9.77M
Gross Profit Q1 2012 · Mar 31, 2012 $36.28M
Gross Profit Q1 2012 · Mar 31, 2011 $27.5M
Cost Of Revenue Q1 2012 · Mar 31, 2012 −$2.26M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $9.22M
Revenue Q1 2012 · Mar 31, 2012 $34.01M
Revenue Q1 2012 · Mar 31, 2011 $36.72M